August 10, 2020 1:12 pm
Cipla stock zoomed 9.99 per cent to Rs 801.45 -- its 52-week high -- on the BSE. It rose sharply by 9.99 per cent to its one-year high of Rs 801.50 on the NSE.
August 05, 2020 5:00 pm
The Mumbai-based drug firm is also ramping up manufacturing of essential drugs required in the fight against the pandemic.
July 09, 2020 7:21 am
Cipla India business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing or dosage.
March 29, 2020 2:26 pm
Amid the coronavirus pandemic, The Indian Express caught up with Cipla chairman Y K Hamied to find out how they are preparing to meet this challenge.
December 17, 2019 11:56 am
The homegrown pharma major on Monday said it has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis.
November 28, 2015 1:36 am
Delhi HC refused to issue any injunction against Cipla restraining it from manufacturing the medicine, after observing that the life of the patent granted to Roche was ending in March 2016.
September 05, 2015 3:07 am
Cipla will as a result of these acquisitions gain multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.
March 11, 2015 1:50 am
Cipla had challenged the patent, arguing that Tiotropium bromide monohydrate, sold under the brand name Spiriva.
January 14, 2015 8:40 am
Cipla had last year started manufacturing and selling a generic drug using the Indacaterol maleate salt.
January 10, 2015 2:24 am
The firm has been selling the drug in India under the trademark ‘Onbrez’ through Lupin since 2010.